(Q38016306)

27 August 2017

title

Risk factors for osteoradionecrosis after head and neck radiation: a systematic review (English)

1 reference

27 August 2017

1 reference

1 reference

Syed Nabil

1

1 reference

27 August 2017

Nabil Samman

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology

27 August 2017

published in

1 reference

27 August 2017

volume

113

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

54-69

1 reference

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

LENT SOMA scales for all anatomic sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Time trial: a prospective comparative study of the time-resource burden for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy in head and neck cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Analysis of complications following megavoltage therapy for squamous cell carcinomas of the tonsillar area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteonecrosis in patients treated with definitive radiotherapy for squamous cell carcinomas of the oral cavity and naso-and oropharynx

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Management of problems of the teeth and jaw in patients undergoing irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Radiation necrosis of the mandible: a 10 year study. Part I. Factors influencing the onset of necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteonecrosis in patients irradiated for head and neck carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: Patterns of fractionation study of radiobiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients--a report of a thirty year retrospective review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Radiotherapy alone or combined with carbogen breathing for squamous cell carcinoma of the head and neck: a prospective, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiothera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfractionation in stage III and IV nasopharyngeal carcinoma--a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Fast-neutron therapy in advanced head and neck cancer: a collaborative international randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Relationship between oral health status and development of osteoradionecrosis of the mandible: a retrospective longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

A study of factors contributing to the development of osteoradionecrosis of the jaws

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Radiation necrosis of the mandible: a 10 year study. Part II. Dental factors; onset, duration and management of necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Studies in the radiobiology of osteoradionecrosis and their clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteoradionecrosis of the jaws: a retrospective study of the background factors and treatment in 104 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteoradionecrosis: a new concept of its pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Postradiation osteonecrosis of the mandible: a long-term follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteoradionecrosis of the mandible resulting from external megavoltage radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Radionecrosis of the mandibula: a retrospective analysis of the incidence and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteoradionecrosis: predisposing factors and outcomes of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteoradionecrosis: clinical experience and a proposal for classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteonecrosis: study of the relationship of dental extractions in patients receiving radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

The conservative management of osteoradionecrosis of the mandible with ultrasound therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Mandibular osteoradionecrosis: clinical behaviour and diagnostic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Mandibular osteoradionecrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Management of dental extractions in irradiated jaws: A protocol without hyperbaric oxygen therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Systematic dental management in head and neck irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Oral care of patients irradiated for cancer of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Preradiation dental extractions and the incidence of bone necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Risk factor assessment for the development of osteoradionecrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Side effects and quality of life after inadvertent radiation overdosage in brachytherapy of head-and-neck cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Incidence of complicated healing and osteoradionecrosis following tooth extraction in patients receiving radiotherapy for treatment of nasopharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

A clinical staging system and treatment guidelines for maxillary osteoradionecrosis in irradiated nasopharyngeal carcinoma patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

The effect of prior radiation therapy for treatment of nasopharyngeal cancer on wound healing following extractions: incidence of complications and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Increased plate and osteosynthesis related complications associated with postoperative concurrent chemoradiotherapy in oral cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteoradionecrosis of the mandible after oromandibular cancer surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Risk factors and dose-effect relationship for osteoradionecrosis after hyperfractionated and conventionally fractionated radiotherapy for oral cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteoradionecrosis with combined mandibulotomy and marginal mandibulectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Contributing factors to mandibulotomy complications: a retrospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Mandibular access osteotomies in oral cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Clinical study of a spacer to help prevent osteoradionecrosis resulting from brachytherapy for tongue cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteoradionecrosis of the jaws

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Osteoradionecrosis of the mandibula in patients treated with different fractionations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Radiation in dentistry—surgical comments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Prevention of osteoradionecrosis of the jaws

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with Mitomycin C and Bleomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Randomized phase II trial of concomitant chemoradiotherapy using weekly carboplatin or daily low-dose cisplatin for squamous cell carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Combined postoperative radiotherapy and Weekly Cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2011.07.042

10.1016/J.TRIPLEO.2011.07.042

7 January 2021

Identifiers

DOI

1 reference

27 August 2017

1 reference